RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

SCI Pharmtech P/E 2024

SCI Pharmtech P/E

38.51

SCI Pharmtech Dividend yield

0.24 %

Ticker

4119.TW

ISIN

TW0004119003

As of May 17, 2024, SCI Pharmtech's P/E ratio was 38.51, a 46.7% change from the 26.25 P/E ratio recorded in the previous year.

The SCI Pharmtech P/E history

SCI Pharmtech Aktienanalyse

What does SCI Pharmtech do?

SCI Pharmtech Inc is a leading company in the pharmaceutical industry based in Zhejiang, China. The company was founded in 2003 and has since grown continuously. Today, the company employs over 100 employees and has become a key player in the global supply chain of pharmaceutical raw materials and intermediates. SCI Pharmtech Inc's business model is based on the development and production of high-quality pharmaceutical intermediates and active pharmaceutical ingredients, as well as the manufacturing of custom chemicals. The company specializes in the production and distribution process, offering its customers a comprehensive range of products that meet the highest quality and safety standards. SCI Pharmtech Inc is divided into various divisions, each specializing in specific product categories. The main divisions are API (Active Pharmaceutical Ingredients), intermediates, and custom synthesis. The API division produces active pharmaceutical ingredients for the pharmaceutical industry, which serve as the basis for drug manufacturing. The intermediates division offers pharmaceutical intermediates used in the synthesis of active pharmaceutical ingredients. The custom synthesis division provides tailored synthesis processes for customers in need of specific chemicals or intermediates. SCI Pharmtech Inc's product portfolio includes Acetamidomalonate, Carbamazepine, and Codergocrine Mesylate, among others. The company also offers custom synthesis services, involving complex chemical syntheses and innovative technologies. SCI Pharmtech Inc places great emphasis on quality and safety. The company operates according to international standards, including GMP (Good Manufacturing Practice), ISO (International Standards Organization), and CE (Conformité Européenne). SCI Pharmtech Inc's products undergo stringent quality controls to ensure compliance with the strict regulations of global pharmaceutical regulatory authorities. Another important concern of SCI Pharmtech Inc is sustainability. The company has developed a sustainable business strategy aimed at minimizing its environmental impact and conserving resources. This includes implementing efficient production processes, reducing energy consumption and CO2 emissions, as well as promoting environmental awareness among employees and customers. Overall, SCI Pharmtech Inc is a dynamic and innovative company specializing in the production of pharmaceutical intermediates and active pharmaceutical ingredients. The company takes pride in offering high-quality products that meet the highest quality and safety standards. Through its sustainable business strategy and adherence to international standards, SCI Pharmtech Inc has achieved an excellent reputation in the pharmaceutical industry and strengthened its presence in the global market. SCI Pharmtech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering SCI Pharmtech's P/E Ratio

The Price to Earnings (P/E) Ratio of SCI Pharmtech is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing SCI Pharmtech's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of SCI Pharmtech is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in SCI Pharmtech’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about SCI Pharmtech Stock

What is the price-to-earnings ratio of SCI Pharmtech?

The price-earnings ratio of SCI Pharmtech is currently 38.51.

How has the price-earnings ratio of SCI Pharmtech changed compared to last year?

The price-to-earnings ratio of SCI Pharmtech has increased by 46.7% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of SCI Pharmtech high compared to other companies?

Yes, the price-to-earnings ratio of SCI Pharmtech is high compared to other companies.

How does an increase in the price-earnings ratio of SCI Pharmtech affect the company?

An increase in the price-earnings ratio of SCI Pharmtech would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of SCI Pharmtech affect the company?

A decrease in the price-earnings ratio of SCI Pharmtech would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of SCI Pharmtech?

Some factors that influence the price-earnings ratio of SCI Pharmtech are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does SCI Pharmtech pay?

Over the past 12 months, SCI Pharmtech paid a dividend of 0.22 TWD . This corresponds to a dividend yield of about 0.24 %. For the coming 12 months, SCI Pharmtech is expected to pay a dividend of 0.22 TWD.

What is the dividend yield of SCI Pharmtech?

The current dividend yield of SCI Pharmtech is 0.24 %.

When does SCI Pharmtech pay dividends?

SCI Pharmtech pays a quarterly dividend. This is distributed in the months of August, August, September, August.

How secure is the dividend of SCI Pharmtech?

SCI Pharmtech paid dividends every year for the past 1 years.

What is the dividend of SCI Pharmtech?

For the upcoming 12 months, dividends amounting to 0.22 TWD are expected. This corresponds to a dividend yield of 0.24 %.

In which sector is SCI Pharmtech located?

SCI Pharmtech is assigned to the 'Health' sector.

Wann musste ich die Aktien von SCI Pharmtech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SCI Pharmtech from 9/1/2023 amounting to 0.222 TWD, you needed to have the stock in your portfolio before the ex-date on 7/27/2023.

When did SCI Pharmtech pay the last dividend?

The last dividend was paid out on 9/1/2023.

What was the dividend of SCI Pharmtech in the year 2023?

In the year 2023, SCI Pharmtech distributed 0.417 TWD as dividends.

In which currency does SCI Pharmtech pay out the dividend?

The dividends of SCI Pharmtech are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von SCI Pharmtech

Our stock analysis for SCI Pharmtech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SCI Pharmtech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.